- Home
- FFAI vs KRRO Comparison
FFAI vs KRRO Comparison
Compare FFAI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFAI
- KRRO
- Stock Information
- Founded
- FFAI 2014
- KRRO 2014
- Country
- FFAI United States
- KRRO United States
- Employees
- FFAI N/A
- KRRO N/A
- Industry
- FFAI
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- FFAI
- KRRO Health Care
- Exchange
- FFAI NYSE
- KRRO Nasdaq
- Market Cap
- FFAI 111.5M
- KRRO 125.4M
- IPO Year
- FFAI N/A
- KRRO 2019
- Fundamental
- Price
- FFAI $1.75
- KRRO $12.90
- Analyst Decision
- FFAI
- KRRO Strong Buy
- Analyst Count
- FFAI 0
- KRRO 7
- Target Price
- FFAI N/A
- KRRO $85.67
- AVG Volume (30 Days)
- FFAI 12.2M
- KRRO 99.7K
- Earning Date
- FFAI 08-13-2025
- KRRO 08-12-2025
- Dividend Yield
- FFAI N/A
- KRRO N/A
- EPS Growth
- FFAI N/A
- KRRO N/A
- EPS
- FFAI N/A
- KRRO N/A
- Revenue
- FFAI $853,000.00
- KRRO $4,821,000.00
- Revenue This Year
- FFAI $115,335.99
- KRRO $65.08
- Revenue Next Year
- FFAI N/A
- KRRO N/A
- P/E Ratio
- FFAI N/A
- KRRO N/A
- Revenue Growth
- FFAI 8.52
- KRRO N/A
- 52 Week Low
- FFAI $0.83
- KRRO $10.29
- 52 Week High
- FFAI $21.89
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- FFAI N/A
- KRRO 51.40
- Support Level
- FFAI N/A
- KRRO $12.27
- Resistance Level
- FFAI N/A
- KRRO $15.15
- Average True Range (ATR)
- FFAI 0.00
- KRRO 1.13
- MACD
- FFAI 0.00
- KRRO 0.25
- Stochastic Oscillator
- FFAI 0.00
- KRRO 57.01
About FFAI FARADAY FUTURE INTELLIGENT ELEC INC
Faraday Future Intelligent Electric Inc is a shared intelligent mobility ecosystem. The company is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models. The company has additional engineering, sales, and operational capabilities in China and plans to develop its manufacturing capability in China through a joint venture.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.